Clinical Trials Browser

Phase 2 × cemiplimab × Plasma cell × Clear all

NCT05669989 2026-05-11

International Treatment-extension Study in Adult Participants With Multiple Myeloma and Who Have Derived Clinical Benefit From Isatuximab

Phase 2 Active not recruiting

Multiple Myeloma